Plasmodium spp. parasites cause malaria in 300 to 500 million individuals each year. Disease occurs during the blood-stage of the parasite's life cycle, where the parasite is thought to replicate exclusively within erythrocytes. Infected individuals can also suffer relapses after several years, from Plasmodium vivax and Plasmodium ovale surviving in hepatocytes. Plasmodium falciparum and Plasmodium malariae can also persist after the original bout of infection has apparently cleared in the blood, suggesting that host cells other than erythrocytes (but not hepatocytes) may harbor these blood-stage parasites, thereby assisting their escape from host immunity. Using blood stage transgenic Plasmodium bergheiexpressing GFP (PbGFP) to track parasites in host cells, we found that the parasite had a tropism for CD317 + dendritic cells. Other studies using confocal microscopy, in vitro cultures, and cell transfer studies showed that blood-stage parasites could infect, survive, and replicate within CD317 + dendritic cells, and that small numbers of these cells released parasites infectious for erythrocytes in vivo. These data have identified a unique survival strategy for blood-stage Plasmodium, which has significant implications for understanding the escape of Plasmodium spp. from immune-surveillance and for vaccine development.
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immune evasion | rodent malaria M alaria commences when an infected female anopheline mosquito bites and deposits, up to 125 Plasmodium sporozoites under the skin of the host (1) . Studies using Plasmodium berghei sporozoites, showed that a proportion will remain in the skin and infect keratinocytes (2) , others are drained by the lymphatic system and are trapped in lymph nodes, and a fraction of the deposited sporozoites enter blood vessels to migrate to the liver (3). In the liver, typically between 1 and 10 sporozoites invade hepatocytes. Other studies have shown that sporozoites can invade and migrate through other cell types, including macrophages (4), Kupffer cells (5, 6) , epithelial cells, and fibroblasts (7) .
The sporozoites within hepatocytes develop by a process of schizogony into merozoite forms, which escape from an infected liver cell into the sinusoid lumen (8) to invade RBC. Within RBC, the merozoites then develop into "ring" trophozoites, then mature trophozoites, and finally a schizont containing up to 32 new merozoites. These schizont-infected RBC then rupture to release merozoites that are able to invade new RBCs, resulting in an increase of parasite biomass. The Plasmodium life cycle continues when some merozoites develop into the sexual parasite stages, the male and female gametocytes, which can be taken up by mosquitoes during blood meals (9) .
Some Plasmodium infections, such as Plasmodium malariae (10) and Plasmodium inui (11) , persist for years and sometimes for the life of the host (12) , and the reasons for this are not understood. To date, the blood-stage parasites of mammalian Plasmodium spp. are thought to survive and replicate only within RBC, but it has long been suspected that they may also have another survival strategy. The blood-stage-parasite of rodent Plasmodium spp. have been observed as sacks of merozoites within macrophages and polymorphonuclear leukocytes (13) . The merozoites were associated with pigment that suggests that cells ingested parasitized RBC (pRBC) as opposed to invasion of the cells by merozoites. These merozoite-associated cells were principally in the spleen, thought to be formed by either pitting or phagocytosis of parasites by macrophages (13) . It is thus possible that this is a site of latency, but proof that the transfer of infection with these cells was not contaminated with infected RBC is lacking. Furthermore, blood-stage parasites have also been found inside platelets (14) but the intrathrombocytic environment did not support parasite growth or replication (15) and infectious studies were not undertaken. Finally, avian Plasmodium also has two stages in which the parasite invades nonerythrocytes: during the initial pre-erythrocytic stages of infection and later in the blood-stage (16) . The infection starts when the sporozoites from the mosquito invade skin mononuclear cells where schizonts develop and release merozoites, which have three phases. These merozoites first invade mononuclear cells throughout the body, develop through schizogony, and are released to invade erythrocytes as part of the second phase. In the final phase, merozoites from erythrocytes invade many different endothelia where the parasite grows (second exo-erythrocytic stage) (16) .
We originally suspected that blood stage Plasmodium spp. might reside within an unidentified cell type and be protected from immunity, when passive transfer of Plasmodia-specific antibodies into immunocompromised mice could significantly reduce but not eliminate parasites in the blood (17) . We then found that CD11c + dendritic cells (DCs) from mice infected with Plasmodium yoelii transferred an infection to naive mice unless the donor mice were treated with antimalarial drugs, suggesting that some parasites might reside within the DCs. Here we demonstrate, predominantly using a transgenic blood-stage P. bergheiexpressing GFP (PbGFP) (18) , that the rodent malaria parasite P. berghei can survive and replicate within CD317 + DCs and that a small percentage of these DCs release parasites that are infectious for erythrocytes on transfer to naive mice.
Results
Blood-Stage Plasmodium Has a Tropism for CD317 + DCs. To determine if DCs could harbor P. berghei, we infected C57/B6 mice with 10 4 blood-stage, transgenic PbGFP (18, 19) . Patent infection (first day of parasites visible on a blood smear) occurs around days 4 to 6 after inoculation (Fig. 1A) , and the infection is usually lethal for mice by day 10 (Fig. 1B) . Because mouse DCs are characterized by expression of CD11c (20) , total CD11c + DCs were isolated from the spleen and from blood of infected mice, following depletion of most major cell types, for studies by flow cytometry. After 7 d in multiple experiments, >20% of spleen CD11c + DCs contained GFP (Fig. 1C) and >85% of CD11c + GFP + DCs also expressed CD317 (Fig. 1D) , labeled by monoclonal antibodies PDCA-1 and 120G8 (21) − DC subpopulations by day 7 postinfection (Fig. S1C ). Absolute numbers of CD317 + DCs were also significantly increased by day 7 (Fig. S1D ). All GFP +
CD11c
+ DCs were "hypermature," as defined by highlevel expression of MHC Class II, CD80, and CD86 (Fig. S1E ). In contrast with the >20% of CD11c + splenic cells, only ∼1% of CD11c + DC in the peripheral blood contained GFP (Fig. S1F ).
Blood-Stage Plasmodium Replicates Within CD317 + DCs. To determine if the GFP seen in DCs represented pRBC, CD317 + DCs were isolated from PbGFP-infected mice, stained with DAPI (4′,6-diamidino-2-phenylindole, which binds DNA), and analyzed by microscopy (Fig. 2) . Multinucleated, DAPI + GFP + parasites were seen within CD317 + DCs ( Fig. 2A, arrow) , and parasites of similar appearance were also visible within Ter119 + pRBC (Fig.  2B, red) . Studies by transmission electron microscopy also showed multinucleated parasites within DCs (Fig. 2 C-E) . Fig. 2D is a magnified image of the inset box shown on Fig. 2C to highlight the parasite has as a parasitophorous vacuole membrane (PVM). Fig.  2E is another higher magnification example of a parasite with multinuclear profiles.
To determine if the multinucleated GFP + parasites seen within DCs were derived from replication within CD317 + DC, these DCs were isolated from spleens of PbGFP-infected mice and cultured for 15 to 18 h in the presence of 5 ethynyl-2′deoxyuridine (EdU) that is incorporated into replicating DNA. The cells were then processed to detect EdU, labeled for CD11c expression and DAPI, and then CD11c + EdU + DAPI + DCs were cell-sorted for confocal microscopy. Multiple EdU + DAPI + small parasite nuclei (arrows) were found inside these DCs (Fig. 2F) , indicating that some parasites were proliferating within the DCs as they had incorporated EdU into their DNA during replication within cultured DCs. These EdU + DAPI + small parasite nuclei did not, however, colocalize with the autophagosome marker LC3 in the same cell (Fig. 2F, arrowhead) . Dividing EdU + DAPI + parasites were never associated with lysosomal or autophagocytic membranes. Other studies found that ∼25% (range of 14-40%) of GFP + CD317 + DCs had replicating parasites at the time of culture, seen by incorporated EdU (Fig. 2G ). This finding was supported by microscopic analysis of ex vivo CD317 + DCs containing GFP + parasites, which found equivalent numbers of DCs had single or multiple green parasites, suggesting many of the infected DCs had probably supported proliferation in vivo (Fig. 2H) .
Additional labeling of CD317 + DCs was undertaken as DCs, by nature, degrade all proteins taken up by endocytosis/pinocytosis except those maintained for transfer to naive B cells (22) . These studies found that when GFP + parasites were adjacent to or colocalized with the late endosome/lysosome markers, LAMP1 (early lysosome associated membrane protein-1) (Fig. 3A , arrowhead) and cathepsin D (Fig. 3B , arrowhead), GFP labeling was reduced, suggestive of parasite degradation. However, there were also GFP + parasites that did not colocalize with these markers ( Fig. 3 A and B, arrows; and Movie S1, which is a 3D reconstruction of a PbGFP-infected CD317 + DCs).
CD317
+ DCs Are Infected in Vitro by P. berghei Schizont-Infected RBC in Culture. In vitro culture followed by adoptive-transfer studies were undertaken to determine if CD317 + DC could be infected in vitro and transfer infection. Total CD11c + DC or CD317 + DC were isolated from naive mice and multiple samples cultured with PbGFP schizont-infected RBC. In parallel, similar numbers of schizont-infected RBC were cultured alone without DCs under similar conditions for 42 to 48 h.
After 24 h, a sample of the CD11c + DCs cultured with parasites was examined by flow cytometry and GFP was found to be predominantly associated with the CD11c lo population of DCs (Fig. 4A) . After 42 to 48 h, aliquots of all parasite cultures with or without DCs were injected intravenously into naive mice (10 6 DC per mouse), which were monitored for infection (Fig. 4B ). All mice given CD11c + DC or CD317 + DC cultured with schizontinfected RBC developed an infection. In contrast, after the 42 to 48 h in culture, no infection was detected in mice given schizontinfected RBC cultured alone. This series of studies showed that the culture conditions used did not support survival of PbGFP schizont-infected RBC, but that CD317 + DCs could support the survival of PbGFP schizont-infected RBC in vitro and infect naive mice on transfer of the DCs. Furthermore, despite extensive attempts, we have never seen red cell membranes surrounding parasites within DCs, suggesting that merozoites may be released by PbGFP schizont-infected RBC in culture and invade DCs.
Demonstration That Infected RBC Were Not the Source of Infection in DC Preparations. Although we could not detect contaminating pRBC by Ter119 labeling of our DC preparations, it could be ar- (Table 1 ). This result demonstrated that our sorting method was highly sensitive in discriminating between infectious and noninfectious cells.
To further demonstrate that contaminating pRBC were not responsible for transferring the infection, CD317 + DCs were isolated from naive mice and mixed with infected RBC in a DC: pRBC ratio of 1:20 or 1:80. One-half of the sample was immediately treated with Gey's solution to lyse RBC, CD317
+ DCs reisolated by MACS (magnetic-activated cell sorting) columns and then labeled with antibody specific for CD11c. The CD11c + DCs were cell-sorted and 10 6 DCs per mouse transferred to naive mice. The other half of the sample was not treated with Gey's solution and adjusted to transfer an equal number of DCs (10 6 per mouse) to naive mice. In duplicate experiments, untreated DC transferred the infection but all DC preparations treated with Gey's solution and isolated failed to transfer infection, confirming our standard DC isolation procedure removed infected RBC.
To demonstrate that cell surface-associated merozoites, released following Gey's lysis of pRBC, were not responsible for the transfer of infection by GFP + CD11c + DCs, blocking studies were undertaken (Fig. 4C) 
Ter119
− DCs were isolated from PbGFP-infected mice, treated with Gey's solution (to free merozoites), followed by incubation with an equal volume of either hyperimmune serum specific for PbGFP (HIS) or naive mouse serum (NMS) before transfusion into naive mice. The treatment of lysed pRBC with HIS delayed the detection of parasitemia in recipient mice by 1 d, with nearly 10-fold lower parasitemia, compared with freed merozoites treated with NMS ( Fig. 4C; Left) . In contrast, HIS did not affect the infectivity of DCs ( Fig. 4C; Right) . These studies showed that the parasites were internalized into DCs and were protected from antibodies capable of neutralizing free merozoites. ) were transferred to groups of naive mice (n = 10) and monitored for the development of blood-stage infections. Using a limiting dilution analysis, it was estimated that ∼1 in 8,631 
− DCs taken from infected mice were infectious ( Fig. 4D Fig. S2 ) which, based on numbers of DCs per spleen, equates to 4,559 infectious DC per spleen (Table 1) .
To determine if CD317 + DCs harbored Plasmodium after the apparent clearance of infection, cohorts of mice were infected with nonlethal P. chabaudi, which clears patent parasitemia within 20 d followed by recurrent bouts of low-level recrudescent parasitemia (Fig. 5A) . Purified CD317 + DCs and infected RBC were taken after 8 d during peak parasitemia and after 20 d, when no parasitized RBC were observed by microscopy, and equal cell numbers (10 5 on day 8 and 10 6 on day 20) transferred to naive recipients. Recipient mice were smeared daily to detect the first appearance of parasites. All mice given RBC or CD317 + DCs taken from mice during peak parasitemia (day 8) developed infections, although the mice given RBC generated higher parasitemia on day 6 posttransfer compared with mice given DC (Fig.  5B) . However, when RBC or CD317 + DCs were taken from mice after the apparent clearance of blood-stage infection (day 20), eight of eight mice given 10 6 CD317 + DCs developed ∼0.67% parasitemia by day 6, compared with five of six mice that received RBC and only developed ∼0.05% (P < 0.0007) parasitemia by the same day (Fig. 5B) . These data show that during the subpatent stage of infection as measured by blood smears, CD317 + DC can harbor parasites and transfer infection more efficiently than the lower level of infection by RBC.
Discussion
This study shows that rodent-infecting blood-stage Plasmodium spp. have a tropism for splenic CD317 + DCs, which can promote their survival and replication and that ∼360 to 4,559 DCs per spleen will sustain infectious parasites. Furthermore, in studies of nonlethal infections with P. chabaudi, these parasitized DCs can release infectious parasites even during subpatent infections. Confocal microscopy studies established that multinucleated parasites were within DCs and not associated with the extracellular membrane folds, as described for the Toxoplasma tachyzoites (23) or associated with extracellular infected RBC. Additional experiments also excluded extraneous RBC or merozoites as being the source of the infection in transfer studies. Furthermore, the observation that only GFP CD317 is a marker of Plasmacytoid DC (PDC) in naive mice but unique DC populations, termed "inflammatory DCs," which are not found in the steady state can appear as a consequence of infection or inflammation (24) and may express this molecule following IFN stimulation (21) . Our data show that the GFP + DCs are heterogeneous in surface expression, but consistent with the infected CD317 + DC being predominantly PDCs because GFP + DCs secreted more IFN-α than GFP − DCs in infected mice (Fig.  S3) ; >50% consistently expressed B220 and Ly6G which are markers of PDC, and <30% were DEC205 + (25) . Furthermore, PDC are long-lived (14-d limit of testing) compared with conventional DCs (<3 d) (25) , and thus we hypothesize would be better able to harbor infectious parasites even after peak parasitemia has cleared. Finally, we were able to show CD317 + DC from naive mice could take up PbGFP from schizont-infected RBC, possibly through invasion as opposed to phagocytosis. These parasites within DCs survived for up to 48 h in vitro and transferred infection to naive mice. Unfortunately, because of the very low numbers of infectious DCs in the spleen and following in vitro infection, we were unable to reliable quantify cell cycle characteristics and determine if the parasites had: (i) a very prolonged cell cycle with a slow development of trophozoites/schizonts; (ii) "arrested forms" that can survive for prolonged periods after which a small percentage develop into infective merozoites; or (iii) a normal cell cycle of 22 to 24 h comparable to asexual blood stages in host RBC which constantly reinfect DC. Based on the low infectivity of DCs on transfer to naive mice and the observation that CD317 + DC can harbor parasites and transfer infection at similar levels during peak and subpatent infections, we hypothesize that these DCs may hold arrested forms of parasites that survive for extended periods. If DCs were constantly reinfected, then like RBC, their infectivity would have been higher during peak parasitemia. Finally, we also suggest that arrested forms would have a survival advantage over just having a prolonged cycle.
Based on our data, we hypothesize that the survival of Plasmodium within immuno-privileged DCs may facilitate evasion from immune surveillance. The observation of blood-stage parasites surviving and replicating only within spleen DCs is consistent with observations of malaria in primates, where it has been shown that primate malaria P. inui persists for the life of the host and infection is only cleared if the spleen is removed after infection (12) . Although some monkeys died from high parasitemia after splenectomy, those that survived were able to clear the infection within 6 mo (12). One explanation for the effect of splenectomy on radical cure of the infection is the possible survival of parasites within DCs in the spleen. This observation also has implications for human malaria. It is known that in patients with a previous history of malaria, often with no new infections for many years, following splenectomy suffer an abrupt onset of Pladmodium falciparum (26), P. malariae (27) , and Plasmodium vivax (28) malarias. These splenectomies usually follow splenic trauma. We thus hypothesize that trauma to the spleen may disturb CD317 + DCs to release parasites and trigger these relapses with malaria.
In conclusion, we have found that CD317 + DCs can support the survival of the blood-stage of rodent malaria parasites, P. berghei, P. chabaudi, and P. yoelii 17XNL. Whether DCs are a reservoir for human Plasmodium spp. remains to be determined. Such findings could have important implications for the development of vaccine strategies and potentially new antimalarial therapeutics.
Materials and Methods
Please refer to the SI Materials and Methods for details, materials, and experimental rationale. DCs from P. yoelii 17XNL infections were transferred to multiple cohorts of naive mice (n = 5-10 per group), which were then smeared every 2 to 5 d to detect infection for up to 30 d. A plot of the log-percent uninfected mice versus number of transferred cells (Fig. 4D and Fig. S2 ) was used to calculate the frequency CD317 + DCs required to transfer infection. Data are representative of two to three independent experiments with similar results. Isolation of Spleen DCs. Total DC populations were enriched from digested spleen cells with Dynabeads Mouse DC enrichment kit (Dynal) and additional Dynal anti-IgM beads. These cell preparations were then passed through MACS columns on a magnet without any prior labeling to deplete hemozoin, residual schizonts, or any other cells containing hemozoin. The DC-enriched cells were then labeled with anti-CD11c or anti-PDCA (CD317) MACS microbeads to isolate total CD11c + DC or CD317 + DC, respectively (Miltenyi Biotec Gmb). 
Ter119
− DCs, CD317 + DCs were isolated from spleens of infected mice using the method described in the previous sections and CD317 + CD11c +
− DC were then cell-sorted.
Confocal Microscopy. GFP + CD11c + CD317 + DCs (day 7) from PbGFP-infected mice were immobilized on poly-L-lysine-coated slides (Sigma) and labeled to detect LAMP1 (BD Bioscience), LC3 (ubiquitin-like protein Atg8, which is a marker of autophagy; clone 5F10; Alexis Biochemicals), Cathepsin D, and nuclear DNA with DAPI (4',6-diamidino-2-phenylindole; Invitrogen), as indicated in the text using immuno-fluorescent-labeling techniques described previously (29) . Microscopy was performed on a Zeiss LSM 510 META confocal microscope (Carl Zeiss).
Electron Microscopy. DCs were isolated as for light microscopy and then processed for standard EM by fixation in glutarahdehyde, postfixation in potassium ferricyanide-reduced osmium tetroxide and uranyl acetate, and embedding in Epon resin following standard protocols.
Preparation of Schizonts. Mature schizonts were isolated from in vitro culture of synchronized ring forms as described by Janse et al. (19) using Nyodenz density-gradient centrifugation (Nycodenz 1.077A; NycoMed) or Optiprep (Axis Shield).
In Vitro Infections of DCs. Total CD11c + DCs or CD317 + DCs were isolated from naive mice (PDC) using MACS and cultured (1-2 × 10 6 per tube) with isolated schizonts in IMDM with 10% FCS in poly styrene tubes, at an approximate ratio of one-to-two schizonts per DC. As controls, equivalent numbers of schizonts were cultured in parallel. After 40 to 48 h, PBS was added to all cultures, cell spun down at 200 × g, resuspended in PBS, transferred to naive mice (5 × 10 5 PDC per mouse) by intravenous injection, and all mice monitored daily for infection. cell sorting from the blood and spleens of PbGFP-infected mice, respectively. All cell preparations were treated with Gey's solution (to free merozoites) for 1 to 2 min. One-half of the preparation was then incubated with hyperimmune serum specific for P. berghei (diluted 1/2 in culture media), produced by repeated infection of mice followed by drug cure with pyrimethamine. The other half was incubated with mouse serum from naive mice (diluted 1/2 in culture media). After 30 min, cohorts of four naive mice were transfused with 10 4 intact pRBC per mouse, lysed-equivalent per mouse or 10 4 DC, and all mice monitored daily for infection.
